من المتوقع أن يصل سوق تسلسل ومقايسة miRNA إلى 468.99 مليون دولار أمريكي بحلول عام 2027 مقارنة بـ 192.31 مليون دولار أمريكي في عام 2019؛ ومن المقدر أن تنمو بمعدل نمو سنوي مركب يبلغ 11.9% من عام 2020 إلى عام 2027.
miRNA عبارة عن جزيء صغير من الحمض النووي الريبي (RNA) غير مشفر يبلغ طوله 20-30 نيوكليوتيد، و فهو يلعب دورًا مهمًا في تنظيم الجينات. نظرًا لأنه مكمل جزئيًا لـ messenger RNA (mRNA)، فإنه يؤدي وظيفة رئيسية تتمثل في تنظيم التعبير الجيني، مما يجعله متحكمًا رئيسيًا في الوظائف الخلوية المهمة. ترتبط miRNAs بالعمليات المرضية مثل الالتهابات الفيروسية وأمراض المناعة الذاتية والتسرطن. وبالتالي، يتم إجراء بحث مكثف لتحديد miRNAs الجديدة. يُعزى نمو سوق تسلسل ومقايسة miRNA بشكل أساسي إلى عوامل مثل اتساع نطاق تطبيقات miRNA وزيادة تمويل أبحاث الجينوم. ومع ذلك، من المتوقع أن تؤدي التحديات المتعلقة بالتسليم والفعالية والخصوصية للعلاجات المستندة إلى miRNA إلى إعاقة نمو السوق.
المناطق المربحة لسوق تسلسل وفحص miRNA
رؤى السوق
نطاق واسع لتطبيقات MicroRNA
miRNAs هي مجموعة من جزيئات RNA الصغيرة وغير المشفرة المكونة من 20-30 نيوكليوتيد. طول. ترتبط هذه الجزيئات بالرنا المرسال المستهدف (mRNA) وتؤدي إلى إسكات الجينات، وبالتالي التحكم في التعبير الجيني. وبالتالي، فإنها تلعب دورًا حاسمًا في فسيولوجيا الخلية وتطورها. تنظم miRNAs جميع الوظائف الخلوية مثل تكاثر الخلايا، والتمايز، وموت الخلايا المبرمج. كونها تشارك في عملية التمايز، فإنها تلعب دورا حاسما في تقديم هوية الأنسجة. ومن ثم، يُعتقد أن miRNAs هي علامة مفيدة في تحديد أنواع الخلايا.
علاوة على ذلك، ترتبط miRNAs أيضًا بالعمليات المرضية مثل الالتهابات الفيروسية، وأمراض المناعة الذاتية، والتسرطن. يمكن لعدد قليل منها أن يعمل كجينات مسرطنة (oncomiRs)، في حين أن العديد منها يعمل كجزيئات miRNA الكابتة للورم. يرتبط التعبير المتغير للmiRNAs بحدوث أنواع مختلفة من السرطان. يتم استكشاف إمكانات miRNAs، جنبًا إلى جنب مع تقنيات التسلسل من الجيل التالي، كفئة جديدة من المؤشرات الحيوية للسرطان. ومن المتوقع أن يكون لهم دور حيوي في تقييم تطور السرطان وتقدمه والتشخيص والتشخيص والعلاج. علاوة على ذلك، ظهرت أيضًا عدة فئات من miRNAs كمؤشرات حيوية واعدة للأمراض المعدية التي تسببها مسببات الأمراض، بما في ذلك فيروس نقص المناعة البشرية وفيروس هيندرا والسل والملاريا.
علاوة على ذلك، أدى الاكتشاف المتعلق بدور miRNAs في تطور المرض إلى ظهور miRNAs هدف رئيسي للنهج العلاجية الجديدة. وصلت العديد من العلاجات التي تستهدف miRNA ضد أمراض مثل السرطان والتهاب الكبد إلى المرحلة السريرية. على سبيل المثال، قامت شركة Santaris Pharma بتطوير جزيء علاجي اسمه Miravirsen يستهدف miR-122 لعلاج عدوى فيروس التهاب الكبد الوبائي (HCV)؛ الجزيء في المرحلة الثانية من التجربة السريرية. لذلك، فإن النطاق المتزايد لتطبيقات miRNAs يقود نمو سوق تسلسل وفحص miRNA.
رؤى قائمة على المنتج
إن سوق تسلسل وفحص miRNA، حسب المنتج، هو مقسمة إلى إعداد المكتبة والمواد الاستهلاكية. استحوذ قطاع المواد الاستهلاكية على حصة أكبر من السوق في عام 2019، في حين من المتوقع أن يسجل قطاع إعداد المكتبات معدل نمو سنوي مركب أعلى في السوق خلال فترة التوقعات.
miRNA سوق التسلسل والمقايسة، حسب المنتج – 2019 و2027
رؤى قائمة على التكنولوجيا
استنادًا إلى التكنولوجيا، يتم تقسيم سوق تسلسل ومقايسة miRNA إلى تسلسل عن طريق التوليف، والمسام النانوية، وأشباه الموصلات الأيونية التسلسل. استحوذ قطاع التسلسل حسب التوليف على الحصة الأكبر من السوق في عام 2019؛ ومع ذلك، من المتوقع أن يسجل قطاع المسام النانوية أعلى معدل نمو سنوي مركب في السوق خلال 2020-2027.
رؤى مستندة إلى المستخدم النهائي
استنادًا إلى بالنسبة للمستخدم النهائي، يتم تقسيم سوق تسلسل ومقايسة miRNA إلى معهد الأبحاث والأوساط الأكاديمية وCROs. استحوذ قطاع معاهد الأبحاث على الحصة الأكبر من السوق في عام 2019 ومن المقدر أن يسجل أعلى معدل نمو سنوي مركب في السوق خلال الفترة من 2020 إلى 2027.
الرؤى الإستراتيجية
التعاون هو إحدى الاستراتيجيات الرئيسية التي يتبناها اللاعبون في سوق تسلسل وفحص miRNA لتوسيع قاعدة العملاء في جميع أنحاء العالم، مما يسمح لهم أيضًا بالحفاظ على اسم علامتهم التجارية عالميًا.
تسلسل وفحص miRNA سوق الفحص – حسب المنتج
- تحضير المكتبة
- المواد الاستهلاكية
سوق تسلسل ومقايسة miRNA - بواسطة التكنولوجيا
- التسلسل عن طريق التخليق
- Nanopore
- تسلسل أشباه الموصلات الأيونية
سوق تسلسل وفحص miRNA &ndash ; بواسطة المستخدم النهائي
- معهد الأبحاث
- الأكاديميين
- CRO
سوق تسلسل وفحص miRNA - بواسطة الجغرافيا
- أمريكا الشمالية
- الولايات المتحدة
- كندا
- المكسيك
< li>أوروبا - فرنسا
- ألمانيا
- إيطاليا
- المملكة المتحدة
- إسبانيا
- الراحة أوروبا
- آسيا والمحيط الهادئ (APAC)
- الصين
- الهند
- كوريا الجنوبية
- اليابان
- أستراليا
- بقية دول آسيا والمحيط الهادئ
- الشرق الأوسط وأفريقيا (MEA)
- جنوب أفريقيا
- المملكة العربية السعودية
- الإمارات العربية المتحدة
- باقي دول الشرق الأوسط وأفريقيا
- الجنوب و أمريكا الوسطى
- البرازيل
- الأرجنتين
- باقي أمريكا الجنوبية والوسطى
 
الملفات التعريفية للشركة
- Illumina Inc.
- Thermo Fisher Scientific Inc.
- Qiagen
- شركة Perkin Elmer
- Takara Bio Inc.
- New England Biolabs
- NorgenBiotek Corp
- TriLinkBioTechnologies Inc
- شركة Lexogen GmbH
- Oxford Nanopore Technologies
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
miRNA is a small non-coding RNA molecule of 20–30-nucleotide length, and it plays an important role in gene regulation. As it is partially complementary to messenger RNA (mRNA), it serves a major function of down-regulating the gene expression, which makes it a key controller of important cellular functions. miRNAs are associated with pathological processes such as viral infections, autoimmune diseases, and carcinogenesis. Thus, extensive research is being conducted to identify new miRNAs.
The growth of the miRNA sequencing and assay market is mainly attributed to the factors such widening range of miRNA applications and rise in funding for genomics research. However, challenges related to delivery, efficacy, and specificity of miRNA-based therapeutics is projected to deter the market growth.
The GMP cytokines market majorly consists of the players such as Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen, Perkin Elmer, Inc., Takara Bio Inc., New England Biolabs, Norgen Biotek Corp, TriLink BioTechnologies Inc, Lexogen GmbH, and Oxford Nanopore Technologies among others.
The List of Companies - MiRNA Sequencing And Assay Market
- Illumina Inc.
- Thermo Fisher Scientific Inc.
- Qiagen
- Perkin Elmer Inc.
- Takara Bio Inc.
- New England Biolabs
- NorgenBiotek Corp
- TriLinkBioTechnologies Inc
- Lexogen GmbH
- Oxford Nanopore Technologies
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Feb 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Feb 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Feb 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Feb 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)